CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade IDEXX Laboratories, Inc. - IDXX CFD

    521.39
    0.53%
    0.51
    Low: 518.97
    High: 527.91
    Market Trading Hours* (UTC) Open now
    Closes on Thursday at 21:00

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.51
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026346 %
    Charges from full value of position ($-5.01)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026346%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004124 %
    Charges from full value of position ($0.78)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004124%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    IDEXX Laboratories Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 518.62
    Open* 518.97
    1-Year Change* 23.05%
    Day's Range* 518.97 - 527.91
    52 wk Range 372.50-564.74
    Average Volume (10 days) 466.89K
    Average Volume (3 months) 10.48M
    Market Cap 39.67B
    P/E Ratio 48.74
    Shares Outstanding 83.05M
    Revenue 3.59B
    EPS 9.80
    Dividend (Yield %) N/A
    Beta 1.25
    Next Earnings Date Feb 5, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 6, 2023 521.39 0.07 0.01% 521.32 529.29 515.97
    Dec 5, 2023 518.62 9.81 1.93% 508.81 519.32 504.87
    Dec 4, 2023 516.36 20.66 4.17% 495.70 517.06 495.70
    Dec 1, 2023 482.24 19.34 4.18% 462.90 483.55 462.22
    Nov 30, 2023 465.69 1.27 0.27% 464.42 466.24 458.11
    Nov 29, 2023 466.29 -4.05 -0.86% 470.34 476.25 464.54
    Nov 28, 2023 470.24 -4.18 -0.88% 474.42 475.46 464.24
    Nov 27, 2023 479.17 4.62 0.97% 474.55 480.35 471.57
    Nov 24, 2023 477.56 3.24 0.68% 474.32 479.62 472.97
    Nov 22, 2023 477.88 -0.41 -0.09% 478.29 483.18 475.02
    Nov 21, 2023 477.57 6.30 1.34% 471.27 479.75 466.57
    Nov 20, 2023 472.77 13.30 2.89% 459.47 473.58 457.37
    Nov 17, 2023 463.45 -3.15 -0.68% 466.60 466.87 456.13
    Nov 16, 2023 466.53 4.81 1.04% 461.72 468.78 460.66
    Nov 15, 2023 460.45 8.19 1.81% 452.26 465.91 449.10
    Nov 14, 2023 454.13 12.77 2.89% 441.36 458.61 441.36
    Nov 13, 2023 432.14 6.49 1.52% 425.65 435.92 424.47
    Nov 10, 2023 428.61 8.01 1.90% 420.60 431.72 414.86
    Nov 9, 2023 418.53 -9.43 -2.20% 427.96 431.83 417.25
    Nov 8, 2023 427.58 1.54 0.36% 426.04 429.67 419.94

    IDEXX Laboratories, Inc. Events

    Time (UTC) Country Event
    Monday, February 5, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 IDEXX Laboratories Inc Earnings Release
    Q4 2023 IDEXX Laboratories Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 3367.32 3215.36 2706.66 2406.91 2213.24
    Revenue 3367.32 3215.36 2706.66 2406.91 2213.24
    Cost of Revenue, Total 1362.99 1325.93 1135.61 1041.36 971.7
    Gross Profit 2004.34 1889.43 1571.04 1365.55 1241.54
    Total Operating Expense 2468.56 2283.33 2012.13 1854.06 1721.91
    Selling/General/Admin. Expenses, Total 847.353 794.295 734.667 678.41 626.644
    Research & Development 254.82 161.009 141.249 133.193 117.863
    Interest Expense (Income) - Net Operating 3.4 2.1 0.6 1.1 3.1
    Operating Income 898.765 932.028 694.524 552.846 491.335
    Interest Income (Expense), Net Non-Operating -38.793 -29.374 -32.539 -30.628 -33.593
    Net Income Before Taxes 859.972 902.654 661.985 522.218 457.742
    Net Income After Taxes 679.089 744.844 582.131 427.792 379.147
    Minority Interest 0 0.001 -0.355 -0.072 -0.016
    Net Income Before Extra. Items 679.089 744.845 581.776 427.72 379.131
    Net Income 679.089 744.845 581.776 427.72 377.031
    Income Available to Common Excl. Extra. Items 679.089 744.845 581.776 427.72 379.131
    Income Available to Common Incl. Extra. Items 679.089 744.845 581.776 427.72 377.031
    Diluted Net Income 679.089 744.845 581.776 427.72 377.031
    Diluted Weighted Average Shares 84.6 86.572 86.722 87.542 88.47
    Diluted EPS Excluding Extraordinary Items 8.02706 8.60376 6.70852 4.88588 4.28542
    Diluted Normalized EPS 8.02706 8.65283 6.73388 4.88588 4.30976
    Unusual Expense (Income) 2.6
    Total Extraordinary Items -2.1
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 943.63 900.195 828.568 841.661 860.546
    Revenue 943.63 900.195 828.568 841.661 860.546
    Cost of Revenue, Total 370.78 357.224 343.641 335.035 346.514
    Gross Profit 572.85 542.971 484.927 506.626 514.032
    Total Operating Expense 647.486 619.796 602.041 596.833 681.48
    Selling/General/Admin. Expenses, Total 230.201 217.905 214.982 213.785 211.745
    Research & Development 46.505 44.667 43.418 48.013 123.221
    Operating Income 296.144 280.399 226.527 244.828 179.066
    Interest Income (Expense), Net Non-Operating -10.215 -12.711 -13.312 -10.645 -7.983
    Net Income Before Taxes 285.929 267.688 213.215 234.183 171.083
    Net Income After Taxes 224.236 214.054 172.207 180.938 131.979
    Minority Interest 0 0 0
    Net Income Before Extra. Items 224.236 214.054 172.207 180.938 131.979
    Net Income 224.236 214.054 172.207 180.938 131.979
    Income Available to Common Excl. Extra. Items 224.236 214.054 172.207 180.938 131.979
    Income Available to Common Incl. Extra. Items 224.236 214.054 172.207 180.938 131.979
    Diluted Net Income 224.236 214.054 172.207 180.938 131.979
    Diluted Weighted Average Shares 83.983 83.959 83.826 84.113 84.858
    Diluted EPS Excluding Extraordinary Items 2.67002 2.54951 2.05434 2.15113 1.55529
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 2.67002 2.54951 2.05434 2.15113 1.55529
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1101.48 955.655 1062.74 679.639 654.172
    Cash and Short Term Investments 112.546 144.454 383.928 90.326 123.794
    Cash & Equivalents 112.546 144.454 383.928 90.326 123.794
    Short Term Investments 0
    Total Receivables, Net 490.903 425.584 374.742 307.487 272.623
    Accounts Receivable - Trade, Net 442.473 406.12 355.266 286.971 258.525
    Total Inventory 367.823 269.03 209.873 195.019 173.303
    Prepaid Expenses 41.742 41.997 34.556 31.992 30.314
    Other Current Assets, Total 88.463 74.59 59.639 54.815 54.138
    Total Assets 2746.76 2437.2 2294.56 1832.47 1537.35
    Property/Plant/Equipment, Total - Net 768.092 692.768 646.338 614.452 437.27
    Property/Plant/Equipment, Total - Gross 1474.01 1341.16 1233.25 1133.48 906.003
    Accumulated Depreciation, Total -705.914 -648.391 -586.914 -519.03 -468.733
    Goodwill, Net 361.795 359.345 243.347 239.724 214.489
    Intangibles, Net 97.672 99.035 52.543 58.468 41.825
    Long Term Investments 55.5 18.598 12.065 13.657 10.894
    Other Long Term Assets, Total 212.541 187.836 179.52 145.349 147.43
    Total Current Liabilities 1235.8 763.579 582.761 725.337 770.444
    Accounts Payable 110.221 116.14 74.558 72.172 69.534
    Accrued Expenses 385.115 416.304 372.972 288.944 233.471
    Notes Payable/Short Term Debt 579 73.5 0 288.765 398.937
    Other Current Liabilities, Total 86.485 82.639 85.243 75.456 68.502
    Total Liabilities 2138.03 1747.21 1662.47 1655 1546.86
    Total Long Term Debt 694.387 775.205 858.492 599.488 499.571
    Long Term Debt 694.387 775.205 858.492 599.488 499.571
    Deferred Income Tax 8.15 8.935 11.707 33.024 29.267
    Minority Interest 0 0.707 0.352 0.28
    Other Liabilities, Total 199.688 199.492 208.806 296.801 247.3
    Total Equity 608.737 689.992 632.088 177.473 -9.513
    Common Stock 15.901 16.407 15.149 15.033 15.033
    Additional Paid-In Capital 1463.21 1377.32 1294.85 1213.52 1138.22
    Retained Earnings (Accumulated Deficit) 3599.53 2920.44 2175.59 1595.65 1167.93
    Treasury Stock - Common -4392.11 -3570.69 -2799.89 -2600.54 -2288.9
    Unrealized Gain (Loss) -0.172 -0.126 -0.272 0.11 -0.157
    Other Equity, Total -77.624 -53.358 -53.343 -46.292 -41.634
    Total Liabilities & Shareholders’ Equity 2746.76 2437.2 2294.56 1832.47 1537.35
    Total Common Shares Outstanding 82.894 84.562 85.449 85.471 86.099
    Note Receivable - Long Term 149.688 123.966 98.01 81.186 31.269
    Current Port. of LT Debt/Capital Leases 74.982 74.996 49.988
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1384.23 1179.03 1149.45 1101.48 1058.86
    Cash and Short Term Investments 331.696 132.838 111.367 112.546 99.176
    Cash & Equivalents 331.696 132.838 111.367 112.546 99.176
    Total Receivables, Net 521.865 532.287 519.861 490.903 452.897
    Accounts Receivable - Trade, Net 503.653 511.982 492.669 442.473 430.327
    Total Inventory 393.974 395.141 391.011 367.823 354.975
    Prepaid Expenses 49.875 38.918 40.084 41.742 39.696
    Other Current Assets, Total 86.82 79.841 87.123 88.463 112.115
    Total Assets 3086.4 2870.81 2808.4 2746.76 2640.07
    Property/Plant/Equipment, Total - Net 804.883 797.418 780.499 768.092 722.508
    Goodwill, Net 361.766 364.206 362.942 361.795 355.292
    Intangibles, Net 87.129 90.932 94.361 97.672 99.968
    Long Term Investments 54.333 55.391 54.271 55.5 51.76
    Note Receivable - Long Term 159.196 159.369 153.757 149.688 142.031
    Other Long Term Assets, Total 234.867 224.465 213.122 212.541 209.649
    Total Current Liabilities 970.193 883.859 1065.63 1235.8 1189.94
    Accounts Payable 112.609 107.664 117.709 110.221 110.144
    Accrued Expenses 370.053 343.016 330.763 385.115 371.286
    Notes Payable/Short Term Debt 250 264 431.5 579 633
    Current Port. of LT Debt/Capital Leases 149.99 74.991 74.986 74.982 0
    Other Current Liabilities, Total 87.541 94.188 110.671 86.485 75.515
    Total Liabilities 1789 1776.94 1967.3 2138.03 2164.07
    Total Long Term Debt 618.813 696.844 696.362 694.387 760.814
    Long Term Debt 618.813 696.844 696.362 694.387 760.814
    Deferred Income Tax 10.594 5.568 5.826 8.15 14.486
    Minority Interest
    Other Liabilities, Total 189.397 190.674 199.48 199.688 198.823
    Total Equity 1297.41 1093.86 841.101 608.737 475.999
    Common Stock 16.268 16.253 15.896 15.901 15.885
    Additional Paid-In Capital 1543.02 1515.2 1489.9 1463.21 1437.53
    Retained Earnings (Accumulated Deficit) 4250.05 4037.82 3813.58 3599.53 3427.32
    Treasury Stock - Common -4437.04 -4401.74 -4401.67 -4392.11 -4323.84
    Unrealized Gain (Loss) -0.166 -0.165 -0.166 -0.172 -0.178
    Other Equity, Total -74.725 -73.5 -76.449 -77.624 -80.716
    Total Liabilities & Shareholders’ Equity 3086.4 2870.81 2808.4 2746.76 2640.07
    Total Common Shares Outstanding 83.068 83.06 83.004 82.894 82.995
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 679.089 744.844 582.131 427.792 377.047
    Cash From Operating Activities 542.984 755.546 648.063 459.158 400.084
    Cash From Operating Activities 111.9 104.596 95.998 88.011 83.178
    Deferred Taxes -35.065 -3.377 -38.082 6.162 1.209
    Non-Cash Items 60.59 47.006 39.777 42.162 30.29
    Cash Taxes Paid 239.8 161.7 110.7 88 69.7
    Cash Interest Paid 39.5 30.5 32.4 29.7 34.7
    Changes in Working Capital -273.53 -137.523 -31.761 -104.969 -91.64
    Cash From Investing Activities -195.35 -292.967 -109.376 -205.528 138.602
    Capital Expenditures -158.838 -119.549 -107.876 -155.224 -122.936
    Other Investing Cash Flow Items, Total -36.512 -173.418 -1.5 -50.304 261.538
    Cash From Financing Activities -370.936 -697.414 -248.416 -286.409 -597.799
    Financing Cash Flow Items -17.472 -20.702 -27.304 -10.582 -10.641
    Issuance (Retirement) of Stock, Net -783.964 -700.212 -131.487 -265.552 -331.118
    Issuance (Retirement) of Debt, Net 430.5 23.5 -89.625 -10.275 -256.04
    Foreign Exchange Effects -8.606 -4.639 3.331 -0.689 -4.768
    Net Change in Cash -31.908 -239.474 293.602 -33.468 -63.881
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 214.054 679.089 506.882 325.944 193.965
    Cash From Operating Activities 183.912 542.984 369.556 180.556 114.706
    Cash From Operating Activities 28.331 111.9 83.18 54.633 26.511
    Deferred Taxes -3.757 -35.065 -36.89 -23.517 -5.028
    Non-Cash Items 15.893 60.59 45.981 30.447 13.5
    Cash Taxes Paid 7.2 239.8 179.72 128.325 11.4
    Changes in Working Capital -70.609 -273.53 -229.597 -206.951 -114.242
    Cash From Investing Activities -39.511 -195.35 -146.121 -96.924 -41.838
    Capital Expenditures -39.511 -158.838 -109.609 -71.924 -41.838
    Other Investing Cash Flow Items, Total -36.512 -36.512 -25 0
    Cash From Financing Activities -146.081 -370.936 -254.216 -105.387 -13.48
    Financing Cash Flow Items -11.377 -17.472 -16.282 -13.206 -10.338
    Issuance (Retirement) of Stock, Net 12.796 -783.964 -722.434 -554.681 -254.642
    Issuance (Retirement) of Debt, Net -147.5 430.5 484.5 462.5 251.5
    Foreign Exchange Effects 0.501 -8.606 -14.497 -8.337 0.776
    Net Change in Cash -1.179 -31.908 -45.278 -30.092 60.164
    Cash Interest Paid 39.5
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.8895 8209522 45187 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2072 5152755 137148 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.5434 3771574 97303 2023-06-30 LOW
    AllianceBernstein L.P. Investment Advisor/Hedge Fund 4.3281 3592832 214529 2023-06-30 LOW
    Fundsmith LLP Investment Advisor 3.5676 2961551 7355 2023-06-30 LOW
    Baron Capital Management, Inc. Investment Advisor/Hedge Fund 2.863 2376632 20389 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.4249 2012999 66660 2023-06-30 LOW
    Invesco Capital Management (QQQ Trust) Investment Advisor 1.7036 1414239 7593 2023-09-30 LOW
    William Blair & Company, L.L.C. (Research) Research Firm 1.4361 1192133 -17061 2023-06-30 LOW
    BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.4199 1178695 -78372 2023-06-30 LOW
    Brown Advisory Investment Advisor/Hedge Fund 1.3987 1161124 24741 2023-09-30 LOW
    Franklin Advisers, Inc. Investment Advisor/Hedge Fund 1.3734 1140082 13910 2023-06-30 LOW
    Fundsmith Investment Services Ltd. Investment Advisor 1.2282 1019528 15108 2023-06-30 LOW
    Capital World Investors Investment Advisor 1.2132 1007073 8310 2023-06-30 LOW
    American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.0103 838655 -196239 2023-06-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9934 824629 49030 2022-12-31 LOW
    Principal Global Investors (Equity) Investment Advisor 0.9692 804548 -82966 2023-06-30 LOW
    BlackRock Asset Management Ireland Limited Investment Advisor 0.9465 785686 -11169 2023-06-30 LOW
    Ayers (Jonathan W) Individual Investor 0.8937 741868 147571 2023-09-06 MED
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.8372 694960 21103 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    IDEXX Labs Company profile

    About IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, IDEXX Laboratories, Inc. revenues increased 19% to $3.22B. Net income increased 28% to $744.8M. Revenues reflect CAG segment increase of 21% to $5.42B, Water segment increase of 14% to $146.5M, United States segment increase of 18% to $2B, Canada segment increase of 30% to $139.7M, Germany segment increase of 23% to $146.8M. Net income benefited from CAG segment income increase of 43% to $824M.

    Equity composition

    Common Stock $.10 Par, 06/11, 120M auth., 98,835,000 issd., less 42,004,000 shs. in Treas. @ $1.16B. Insiders control approx.1.09%. IPO: 4/92, 1.5M shares @ $20.50 by Lehman Brothers. PO: 10/95, 4.6M shares @ $35 by Cowen & Company. 11/07, 6/95 & 10/93, 2-for-1 stock splits. 06/15, 2-for-1, Stock Split.

    Industry: Veterinary Medical Equipment & Supplies

    One Idexx Drive
    WESTBROOK
    MAINE 04092-2041
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    XRP/USD

    0.64 Price
    -0.960% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    70.54 Price
    +1.680% 1D Chg, %
    Long position overnight fee -0.0205%
    Short position overnight fee -0.0014%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    US100

    15,880.30 Price
    +0.570% 1D Chg, %
    Long position overnight fee -0.0263%
    Short position overnight fee 0.0041%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    43,272.50 Price
    -1.360% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading